Kardigan, Inc.
NASDAQ:KARDBiotechnology
Healthcare
$12.32 +3.50%
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
52W Low $16.25High $24.00
Volume 0.55M
Average 5.84M
KARD Sales of Investments
Cash received from selling or redeeming investments.
No reported Sales of Investments figures are available to summarize.
Sales of Investments history
Currency unavailable · from the cash flow
No Sales of Investments data reported for this period type.
Sales of Investments vs competitors
How KARD compares with its peers on the latest reported figures
KARD Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.04B USD | +8.1% | +22.4% | 1460.6% | |
| LTM Jun 2026 | $182.4M USD | +390.8% | — | 2561.4% | |
| LTM Mar 2026 | $34.02M USD | -63.1% | -38.6% | 15118.2% | |
| LTM Mar 2026 | $30.19M USD | -24.2% | +103.1% | — | |
| FY2025 | $0 USD | — | — | 0.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -8.1% | +22.4% | 2011.0% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.